CollPlant Biotechnologies Ltd (CLGN)

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT PR Newswire REHOVOT, Israel, June 30...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR...

Form 3 - Initial statement of beneficial ownership of securities

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

AbbVie ends CollPlant deal and slashes workforce to cut costs

CollPlant Biotechnologies (NASDAQ:CLGN) said its collaboration with AbbVie (NYSE:ABBV) has been terminated, prompting the company to implement...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CollPlant Issues Letter to Shareholders

CollPlant Issues Letter to Shareholders PR Newswire REHOVOT, Israel, April 13, 2026 REHOVOT, Israel...

Form F-1 - Registration statement for certain foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire REHOVOT...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]